Botensilimab Plus Balstilimab Improves Outcomes in Recurrent Platinum-Resistant/-Refractory Ovarian Cancer

In patients with recurrent platinum-resistant/-refractory ovarian cancer, treatment with botensilimab (Agenus), a ...

APRIL 26, 2023